Dr Reddy's, RDIF commence clinical trials for Sputnik vaccine

Dr Reddy's Laboratories Ltd and the Russian Direct Investment Fund (RDIF) on Tuesday announced commencement of adaptive phase 2/3 clinical trials for COVID-19 vaccine Sputnik V in India after receiving necessary clearance from the Central Drugs Laboratory, Kasauli in Himachal Pradesh.